Prevalence of High Blood Pressure in the Population Covered by Mashhad University of Medical Sciences, Mashhad, Iran, during 2017

Document Type: Original Article

Authors

1 Family Medicine Specialist, Department of Family Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Epidemiologist, Department of Epidemiology, Biostatistics, School of Health, Social Determinants of Health Research Center, Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 PhD Candidate in Epidemiology, Khorasan Razavi Province Health Center, Mashhad University of Medical Sciences, Mashhad, Iran

4 Internal Medicine, Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Introduction: High blood pressure is one of the most important risk factors for cardiovascular diseases. Hypertension has different prevalence rates across the world. The aim of this study was to determine the prevalence of high blood pressure in the middle-aged and elderly population covered by the Mashhad University of Medical Sciences, Mashhad, Iran.
Materials and Methods: This analytical cross-sectional study was carried out on the secondary data of SINA (Integrated Health Information System) performed on 246,904 people, aged ≥ 30 years, registered in 2017. Diagnostic testing was performed according to the clinical guidelines of the Seventh Report of the Joint National Committee on Prevention, Detection, and Evaluation (JNC7). The data were analyzed using the SPSS software, version 22. Chi-square tests were used to analyze the relationships between the variables. A p-value less than 0.05 was considered statistically significant.
Results:The overall prevalence of hypertension was estimated at 32.3%. With regard to gender distribution, the prevalence of this disorder among males and females was obtained as 32% and 32.5%, respectively. Additionally, this disorder had the prevalence rates of 25.3% and 38.8% in cities and villages, respectively.
Conclusion:It seems that the prevalence of high blood pressure is higher in the studied population than in those living in many parts of Iran and the world. Accordingly, it is required to plan serious interventions in this regard.

Keywords


1.Harrison TR. Harrison's principle of internal medicine. 19th Edition ed. Harrison TR eUSM-HCp.

2.Ingale AS DJ, Health P. Prevalence of hypertension and its associated risk factors in adults: a unique study at field practice area of urban health training centre. 2017;4(2):572-81.

3.Liu F AD, Xie X, Li X-M, Fu Z-Y, Shan C-F, et al. Prevalence of isolated diastolic hypertension and associated risk factors among different ethnicity groups in Xinjiang, China. 2015;10(12):e0145325.

4.Unwin N SP, Rashid S, Mugusi F, Mbanya J-C, Kitange H, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? 2001;79:947-53.

5.Mills KT BJ, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and ControlClinical Perspective: A Systematic Analysis of Population-Based Studies From 90 Countries. 2016;134(6):441-50.

6.Yoon SS FC, Carroll MD. Hypertension prevalence and control among adults: United States, 2011-2014: US Department of Health and Human Services, Centers for Disease Control and; 2015.

7.Gu D RK, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. 2002;40(6):920-7.

8.Mohammadi E AH, Gofranipour F, Jalali FJIjonp. Partnership caring: a theory of high blood pressure control in Iranian hypertensives. 2002;8(6):324-9.

9.Mbanya J ME, Salah J, Balkau BJIjoe. The prevalence of hypertension in rural and urban Cameroon. 1998;27(2):181-5.

10.Whelton PKJL. Epidemiology of hypertension. 1994;344(8915):101-6.

11.Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh FJG, international g. Trend of cardiovascular risk factors in the older Iranian population: 2002–2014. 2018;18(1):130-7.

12.Mohsenzadeh Y MM, Hemmati F, Sayehmiri K, Sarokhani MT, Sarokhani DJJoBRiMS. Investigating the prevalence rate of hypertension in Iranian men and women: A study of systematic review and meta-analysis. 2017;4(1):53-62.

13.Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh FJG, international g. Trend of cardiovascular risk factors in the older Iranian population: 2002–2014. 2018;18(1):130-7.

14.Robert E. Rakel DPR. Textbook of Family Medicine. NINTH EDITION ed. United States: Elsevier. 1447 p.

15.Anchala R KN, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. 2014;32(6):1170.

16.Chethana K AT, Mane A, Prasad VM, Sunkad VMJIJOCM, Health P. Prevalence of hypertension and its risk factors among adults in urban field practice area NMC, Raichur, Karnataka, India. 2016;4(1):45-50.

17.Chethana K, Anusha T, Mane A, Prasad VM, Sunkad VMJIJOCM, Health P. Prevalence of hypertension and its risk factors among adults in urban field practice area NMC, Raichur, Karnataka, India. 2016;4(1):45-50.

18.Jolly SE KK, Metzger JS, Day GM, Silverman A, Hopkins SE, et al. Prevalence of hypertension and associated risk factors in western alaska native people: The Western Alaska Tribal Collaborative for Health (WATCH) Study. 2015;17(10):812-8.

19.Kingue S NC, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B, et al. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population‐based cross‐sectional study. 2015;17(10):819-24.

20.Pinto IC MD, Therapeutics. Prevalence and risk factors of arterial hypertension: A literature review. 2017;1(2):1-7.

21.Do HT GJ, Le MB, Kok FJ, Feskens EJJAjoh. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults. 2014;28(1):89-97.

22.Joshi MD AR, Njau EK, Wanjiru R, Kayima JK, Njeru EK, et al. Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: a population-based survey. 2014;14(1):1177.

23.Yang L YJ, Tang X, Xu X, Yu W, Wu HJPo. Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in Southern China, 2013. 2016;11(1):e0146181.

24.Ebrahimi M MM, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006. Journal of hypertension. 2010;28(8):1620-9.

25.Esteghamati A AM, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. American journal of hypertension. 2008;21(6):620-6.

26.Sadeghi M RH, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. The Medical journal of Malaysia. 2004;59(4):460-7.

27.Ghorbani R, et al., Prevalence of hypertention among the adult population of Semnan province. Iraninan Journal of Endocrinology and MetabolismR(IJEM), 2009. 10(5 (SN 41)).

28.Taheri Tanjani P, et al.,Health status of elderly people in Khuzestan: A cross-sectional study. Iranian Journal of Diabetes and Lipid Disorders, 2017. 16(4): p. 191-200.

29.Lloyd-Sherlock P BJ, Minicuci N, Ebrahim S, Chatterji SJIjoe. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. 2014;43(1):116-28.

30.          Najafi B, et al.,  Health status of elderly people in Sistan and Baluchistan province. Iranian Journal of Diabetes and Lipid Disorders, 2017. 16(5): p. 283-292.

31.Bromfield SG BC, Tanner RM, Peralta CA, Odden MC, Oparil S, et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988–2010. 2014;16(4):270-6.

32.Delavari A, et al., Prevalence of hypertention in iranian urban and rural populations aged over 20 years in 2004 Journal of Mazandaran university of medical science,2007. 17(58).